Clinical Research Directory
Browse clinical research sites, groups, and studies.
Population Pharmacokinetics of Metronidazole in Neonates
Sponsor: Rennes University Hospital
Summary
The objective of NEOPOPI is to conduct a population pharmacokinetic study of metronidazole in neonates, in order to evaluate and optimize neonatal dose regimen. There will be no change to the medication treatment received by participants. An opportunistic pharmacokinetic sampling approach will be followed: samples will be scavenged from blood or cerebrospinal fluid drawn for routine biochemical tests. In this way, no additional invasive tests will be needed.
Official title: Population Pharmacokinetics of Metronidazole in Neonates: Evaluation and Optimization of the Dose
Key Details
Gender
All
Age Range
Any - 44 Weeks
Study Type
OBSERVATIONAL
Enrollment
171
Start Date
2020-05-29
Completion Date
2021-08-13
Last Updated
2026-06-12
Healthy Volunteers
No
Conditions
Locations (7)
CHU d'Angers
Angers, France
CHU de Brest
Brest, France
Centre Robert Debré
Paris, France
CHU de Rennes
Rennes, France
CH St Brieuc
Saint-Brieuc, France
CHU de Tours
Tours, France
CH Vannes
Vannes, France